1. Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011;32:157-64.

2. Boyapati RK, Tamborska A, Dorward DA, Ho GT. Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Res 2017;6:169.

3. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, et al. Oxidized mitochondrial DNA activated the NRLP3 inflammasome during apoptosis. Immunity 2012;36:401-14.

4. O’Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol 2016;16:553-65.

5. Russell DG, Huang L, VanderVen BC. Immunometabolism at the interface between macrophages and pathogens. Nat Rev Immunol 2019;19:291-304.

6. Lynch MA. Can the emerging field of immunometabolism provide insights into neuroinflammation? Prog Neurobiol 2020;184:101719.

7. Ghosh M, Xu Y, Pearse DD. Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines. J Neuroinflammation 2016;13:9.

8. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 2014;17:131-43.

9. Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, et al. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 2012;60:717-27.

10. Finsen B, Owens T. Innate immune responses in central nervous system inflammation. FEBS Lett 2011;585:3806-12.

11. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010;330:841-5.

12. Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, et al. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci 2013;16:1896-905.

13. Holtman IR, Skola D, Glass CK. Transcriptional control of microglia phenotypes in health and disease. J Clin Invest 2017;127:3220-9.

14. Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J Clin Invest 2012;122:1164-71.

15. Crotti A, Ransohoff RM. Microglial physiology and pathophysiology: insights from genome-wide transcriptional profiling. Immunity 2016;44:505-15.

16. Borst K, Schwabenland M, Prinz M. Microglia metabolism in health and disease. Neurochem Int 2019;130:104331.

17. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57:173-85.

18. Hermann DM, El-Ali A. The abluminal endothelial membrane in neurovascular remodeling in health and disease. Sci Signal 2012;5:re4.

19. Ifergan I, Kébir H, Bernard M, Wosik K, Dodelet-Devillers A, et al. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 2008;131:785-99.

20. Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, et al. Immunologic privilege in the central nervous system and the blood-brain barrier. Cereb Blood Flow Metab 2013;33:13-21.

21. Banerjee S, Bhat MA. Neuron-glial interactions in blood-brain barrier formation. Annu Rev Neurosci 2007;30:235-58.

22. King IL, Dickendesher TL, Segal BM. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009;113:3190-7.

23. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci 2007;12:1544-53.

24. Vallieres L, Sawchenko PE. Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci 2003;23:5197-207.

25. Trifilo MJ, Montalto-Morrison C, Stiles LN, Hurst KR, Hardison JL, et al. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J Virol 2003;78:585-94.

26. González H, Pacheco R. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflam 2014;11:201.

27. Li J1, Gran B, Zhang GX, Ventura ES, Siglienti I, et al. Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. J Neurol Sci 2003;215:95-103.

28. Romero-Suárez S, Del Rio Serrato A, Bueno RJ, Brunotte-Strecker D, Stehle C, et al. The central nervous system contains ILC1s that differ from NK cells in the response to inflammation. Front Immunol 2019;10:2337.

29. Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol 2014;14:392-404.

30. Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med 2014;211:1533-49.

31. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005;8:752-8.

32. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005;308:1314-8.

33. Chiu IM, Morimoto ET, Goodarzi H, Liao JT, O’Keeffe S, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep 2013;4:385-401.

34. Angata T, Kerr SC, Greaves DR, Varki NM, Crocker PR, et al. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J Biol Chem 2002;277:24466-74.

35. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005;201:647-57.

36. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-84.

37. Wilkinson K, El Khoury J. Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer’s disease. Int J Alzheimers Dis 2012;2012:489456.

38. Pei Z, Pang H, Qian L, Yang S, Wang T, et al. MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity. Glia 2007;55:1362-73.

39. Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010;10:826-37.

40. Shechter R, Schwartz M. CNS sterile injury: just another wound healing? Trends Mol Med 2013;19:135-43.

41. McPherson CA, Merrick BA, Harry GJ. In vivo molecular markers for pro-inflammatory cytokine M1 stage and resident microglia in trimethyltin-induced hippocampal injury. Neurotox Res 2014;25:45-56.

42. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008;8:279-89.

43. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-20.

44. Biber K, Neumann H, Inoue K, Boddeke HW. Neuronal ‘On’ and ‘Off’ signals control microglia. Trends Neurosci 2007;30:596-602.

45. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007;10:1387-94.

46. Ransohoff RM, Cardona AE. The myeloid cells of the central nervous system parenchyma. Nature 2010;468:253-62.

47. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev 2011;91:461-553.

48. Domercq M, Vázquez-Villoldo N, Matute C. Neurotransmitter signaling in the pathophysiology of microglia. Front Cell Neurosci 2013;7:49.

49. Kierdorf K, Prinz M. Factors regulating microglia activation. Front Cell Neurosci 2013;7:44.

50. Pocock JM, Kettenmann H. Neurotransmitter receptors on microglia. Trends Neurosci 2007;30:527-35.

51. Garcia-Revilla J, Alonso-Bellido IM, Burguillos MA, Herrera AJ, Espinosa-Oliva AM. Reformulating pro-oxidant microglia in neurodegeneration. J Clin Med 2019;8:1719.

52. Lee JK, Chung J, Kannarkat GT, Tansey MG. Critical role of regulator G-protein signaling 10 (RGS10) in modulating macrophage M1/M2 activation. PLoS One 2013;8:e81785.

53. Seifert S, Pannell M, Uckert W, Färber K, Kettenmann H. Transmitter- and hormone-activated Ca(2+) responses in adult microglia/brain macrophages in situ recorded after viral transduction of a recombinant Ca(2+) sensor. Cell Calcium 2011;49:365-75.

54. Ajami B, Samusik N, Wieghofer P, Ho PP, Crotti A, et al. Single-cell mass cytometry reveals distinct populations of brain myeloid cells in mouse neuroinflammation and neurodegeneration models. Nat Neurosci 2018;21:541-51.

55. Pettersen JS, Fuentes-Duculan J, Suárez-Fariñas M, Pierson KC, Pitts-Kiefer A, et al. Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. J Invest Dermatol 2011;131:1322-30.

56. Ziegler-Heitbrock L, Hofer TPJ. Toward a refined definition of monocyte subsets. Front Immunol 2013;4:23.

57. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-69.

58. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.

59. Lynch MA. The multifaceted profile of activated microglia. Mol Neurobiol 2009;40:139-56.

60. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010;11:889-96.

61. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012;122:787-95.

62. Hume DA, Freeman TC. Transcriptomic analysis of mononuclear phagocyte differentiation and activation. Immunol Rev 2014;262:74-84.

63. Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009;4:399-418.

64. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 2009;210:3-12.

65. Boche D, Perry VH, Nicoll JA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 2013;39:3-18.

66. Cherry JD, Olschowka JA, O’Banion MK. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 2014;11:98.

67. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014;41:14-20.

68. Loane D, Kumar A. Microglia in the TBI Brain: the good, the bad, And the dysregulated. Exp Neurol 2016;275:316-27.

69. Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 2016;173:649-65.

70. Gerrick KY, Gerrick ER, Gupta A, Wheelan SJ, Yegnasubramanian S, et al. Transcriptional profiling identifies novel regulators of macrophage polarization. PLoS One 2018;13:e0208602.

71. Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci 2016;19:987-91.

72. Stein M. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992;176:287-92.

73. Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, et al. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur J Immunol 1994;24:1441-5.

74. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014;6:1-13.

75. Mills EL, O’Neill LA. Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal. Eur J Immunol 2016;46:13-21.

76. Murray PJ. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 2006;6:379-86.

77. Bordt EA, Polster BM. NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair? Free Radic Biol Med 2014;76:34-46.

78. Dashty M. A quick look at biochemistry: carbohydrate metabolism. Clin Biochem 2013;46:1339-52.

79. Liemburg-Apers DC, Schirris TJ, Russel FG, Willems PH, Koopman WJ. Mitoenergetic dysfunction triggers a rapid compensatory increase in steady-state glucose flux. Biophys J 2015;109:1372-86.

80. Vazquez A, Liu J, Zhou Y, Oltvai ZN. Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited. BMC Syst Biol 2010;4:58.

81. Warburg O. On respiratory impairment in cancer cells. Science 1956;124:269-70.

82. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-33.

83. Weinberg SE, Sena LA, Chandel NS. Mitochondria in the regulation of innate and adaptive immunity. Immunity 2015;42:406-17.

84. Kelly B, O’Neill LA. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res 2015;25:771-84.

85. Mehta MM, Weinberg SE, Chandel NS. Mitochondrial control of immunity: beyond ATP. Nat Rev Immunol 2017;17:608-20.

86. Viola A, Munari F, Sanchez-Rodriguez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. Front Immunol 2019;10:1462.

87. Zuo H, Wan Y. Metabolic reprogramming in mitochondria of myeloid cells. Cells 2020;9:5.

88. Biswas SK, Mantovani A. Orchestration of metabolism by macrophages. Cell Metab 2012;15:432-7.

89. Ryan DG, O’Neill LAJ. Krebs cycle reborn in macrophage immunometabolism. Annu Rev Immunol 2020. Epub ahead of print. doi: 10.1146/annurev-immunol-081619-104850

90. Bernhart E, Kollroser M, Rechberger G, Reicher H, Heinemann A. Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture. Proteomics 2010;10:141-58.

91. Moss DW, Bates TE. Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur J Neurosci 2001;13:529-38.

92. Zuo H, Wan Y. Metabolic reprogramming in mitochondria of myeloid cells. Cell 2020;9:5.

93. Lartigue L, Faustin B. Mitochondria: Metabolic regulators of innate immune responses to pathogens and cell stress. Int J Biochem Cell Biol 2013;45:2052-56.

94. Voloboueva LA, Emery JF, Sun X, Giffard RG. Inflammatory response of microglial BV-2 cells includes a glycolytic shift and is modulated by mitochondrial glucose-regulated protein 75/mortalin. FEBS Lett 2013;587:756-62.

95. Gimeno-Bayon J, Lopez-Lopez A, Rodriguez MJ, Mahy N. Glucose pathways adaptation supports acquisition of activated microglia phenotype. J Neurosci Res 2014;92:723-31.

96. Chenais B, Morjani H, Drapier JC. Impact of endogenous nitric oxide on microglial cell energy metabolism and labile iron pool. J Neurochem 2002;81:615-23.

97. Rodríguez-Prados JC, Través PG, Cuenca J, Rico D, Aragones J, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol 2010;185:605-14.

98. Odegaard JI, Chawla A. Alternative macrophage activation and metabolism. Annu Rev Pathol 2011;6:275-97.

99. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013;229:176-85.

100. Galvan-Pena S, O’Neill LA. Metabolic reprograming in macrophage polarization. Front Immunol 2014;5:420.

101. Mills EL, Kelly B, O’Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol 2017;18:488-98.

102. Newsholme P, Curi R, Gordon S, Newsholme EA. Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem J 1986;239:121-5.

103. Newsholme P, Gordon S, Newsholme EA. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J 1987;242:631-6.

104. Haschemi A, Kosma P, Gille L, Evans CR, Burant CF, et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab 2012;15:813-26.

105. Blagih J, Jones RG. Polarizing macrophages through reprogramming of glucose metabolism. Cell Metab 2012;15:793-5.

106. Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, et al. ATP synthesis and storage. Purinergic Signal 2012;8:343-57.

107. Bernier LP, Bohlen CJ, York EM, Choi HB, Kamyabi A, et al. Nanoscale surveillance of the brain by microglia via cAMP-regulated filopodia. Cell Reports 2019;27:2895-908.

108. Madry C, Kyrargyri V, Arancibia-Carcamo IL, Jolivet R, Kohsaka S, et al. Microglial ramification, surveillance, and interleukin-1beta release are regulated by the two-pore domain K(+) channel THIK-1. Neuron 2018;97:299-312.

109. Ghosh S, Castillo E, Frias ES, Swanson RA. Bioenergetic regulation of microglia. Glia 2018;66:1200-12.

110. Cherry JD, Olschowka JA, O’Banion MK. Are ‘resting’ microglia more ‘m2’? Front Immunol 2014;5:594.

111. Baik SH, Kang S, Lee W, Choi H, Chung S, et al. A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer’s disease. Cell Metab 2019;30:493-507.e6.

112. Holland R, McIntosh AL, Finucane OM, Mela V, Rubio-Araiz A, et al. Inflammatory microglia are glycolytic and iron retentive and typify the microglia in APP/PS1 mice. Brain Behav Immun 2017;68:183-96.

113. McIntosh A, Mela V, Harty C, Minogue AM, Costello DA, et al. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice. Brain Pathol 2019;29:606-21.

114. Wang T, Liu H, Lian G, Zhang SY, Wang X, et al. HIF1 α -induced glycolysis metabolism is essential to the activation of inflammatory macrophages. Mediators Inflamm 2017;2017:1-10.

115. Nair S, Sobotka KS, Joshi P, Gressens P, Fleiss B, et al. Lipopolysaccharide-induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo. Glia 2019;67:1047-61.

116. Chénais B, Morjani H, Drapier JC. Impact of endogenous nitric oxide on microglial cell energy metabolism and labile iron pool. J Neurochem 2002;81:615-23.

117. Banati RB, Egensperger R, Maassen A, Hager G, Kreutzberg GW, et al. Mitochondria in activated microglia in vitro. J Neurocytol 2004;33:535-41.

118. Ferger AI, Campanelli L, Reimer V, Muth KN, Merdian I, et al. Effects of mitochondrial dysfunction on the immunological properties of microglia. J Neuroinflamm 2010;7:45.

119. Finucane OM, Sugrue J, Rubio-Araiz A, Guillot-Sestier MV, Lynch MA. The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1beta dependent manner in macrophages. Sci Rep 2019;9:4034.

120. Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 2017;356:513-9.

121. Murray PJ, Wynn TA. Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol 2011;89:557-63.

122. Biswas SK, Chittezhath M, Shalova IN, Lim JY. Macrophage polarization and plasticity in health and disease. Immunol Res 2012;53:11-24.

123. Huang SC, Everts B, Ivanova Y, O’Sullivan D, Nascimento M, et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol 2014;15:846-55.

124. Liu PS, Wang H, Li X, Chao T, Teav T, et al. Alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol 2017;18:985-94.

125. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, et al. Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation. Cell Metab 2006;4:13-24.

126. Mills CD, Kincaid K, Alt JM, Hellman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000;164:6166-73.

127. De Simone R, Ajmone-Cat MA, Pandolfi M, Bernardo A, De Nuccio C, et al. The mitochondrial uncoupling protein-2 is a master regulator of both M1 and M2 microglial responses. J Neurochem 2015;135:147-56.

128. West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011;472:476-80.

129. Van den Bossche J, Baardman J, Otto NA, van der Velden S, Neele AE. Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep 2016;17:684-96.

130. Poderoso JJ, Helfenberger K, Poderoso C. The effect of nitric oxide on mitochondrial respiration. Nitric Oxide 2019;88:61-72.

131. Hu Y, Mai W, Chen L, Cao K, Zhang B, et al. mTOR-mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysaccharide and ATP. Glia 2020;68:1031-45.

132. Li D, Wang C, Yao Y, Chen L, Liu G, et al. mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type. FASEB J 2016;30:3388-99.

133. Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, et al. TREM2 maintains microglial metabolic fitness in alzheimer’s disease. Cell 2017;170:649-63.e13.

134. Zhao X, Liao Y, Morgan S, Mathur R, Feustel P, et al. Noninflammatory changes of microglia are sufficient to cause epilepsy. Cell Rep 2018;22:2080-93.

135. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245-313.

136. Pawate S, Shen Q, Fan F, Bhat NR. Redox regulation of glial inflammatory response to lipopolysaccharide and interferon gamma. J Neurosci Res 2004;77:540-51.

137. Qin L, Liu Y, Wang T, Wei SJ, Block ML, et al. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 2004;279:1415-21.

138. Loane DJ, Stoica BA, Pajoohesh-Ganji A, Byrnes KR, Faden AI. Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. J Biol Chem 2009;284:15629-39.

139. Choi SH, Aid S, Kim HW, Jackson SH, Bosetti F. Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. J Neurochem 2012;120:292-301.

140. Eguchi H, Fujiwara N, Sakiyama H, Yoshihara D, Suzuki K. Hydrogen peroxide enhances LPS-induced nitric oxide production via the expression of interferon beta in BV-2 microglial cells. Neurosci Lett 2011;494:29-33.

141. Mander PK, Jekabsone A, Brown GC. Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase. J Immunol 2006;176:1046-52.

142. Roy A, Jana A, Yatish K, Freidt MB, Fung YK, et al. Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: implications for neurodegenerative diseases. Free Radic Biol Med 2008;45:686-99.

143. Taetzsch T, Levesque S, McGraw C, Brookins S, Luqa R, et al. Redox Regulation of NF-κB p50 and M1 Polarization in Microglia. Glia 2015;63:423-40.

144. Yuan YH, Sun JD, Wu MM, Hu JF, Peng SY, et al. Rotenone could activate microglia through NF-kB associated pathway. Neurochem Res 2013;38:1553-60.

145. Kletzien RF, Harris PK, Foellmi LA. Glucose-6-phosphate dehydrogenase: a “housekeeping” enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J 1994;8:174-81.

146. Salvemini F, Franzé A, Iervolino A, Filosa S, Salzano S, et al. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J Biol Chem 1999;274:2750-7.

147. Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000;346:1-8.

148. Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 2008;10:179-206.

149. Shen Y, Kapfhamer D, Minnella AM, Kim JE, Won SJ, et al. Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP. Nat Commun 2017;8:624.

150. Wang L, Pavolu S, Du X, Bhuckory M, Xu H, et al. Glucose transporter 1 critically controls microglial activation through facilitating glycolysis. Mol Neurodegener 2019;14:2.

151. Kalsbeek MJ, Mulder L, Yi CX. Microglia energy metabolism in metabolic disorder. Mol Cell Endocrinol 2016;438:27-35.

152. Payne J, Maher F, Simpson I, Mattice L, Davies P. Glucose transporter Glut 5 expression in microglial cells. Glia 1997;21:327-31.

153. Hsieh C, Liu C, Lee C, Yu LE, Wang JY. Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation. Sci Rep 2019;9:840.

154. Chen J, Sun Z, Jin M, Tu Y, Wang S, et al. Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway. J Neuroimmunol 2017;305:108-14.

155. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 2013;496:238-42.

156. O’Neill LAJ, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med 2016;213:15-23.

157. Wang F, Zhang S, Jeon R, Vuckovic, Jiang X, et al. Interferon gamma induces reversible metabolic reprogramming of M1 macrophages to sustain cell viability and pro-inflammatory activity. EbioMedicine 2018;30:303-16.

158. Choi SJ, Shin IJ, Je KH, Min EK, Kim EJ, et al. Hypoxia antagonizes glucose deprivation on interleukin 6 expression in an Akt dependent, but HIF-1/2α independent manner. PLoS One 2013;8:e58662.

159. Churchward MA, Tchir DR, Todd KG. Microglial function during glucose deprivation: inflammatory and neuropsychiatric implications. Mol Neurobiol 2018;55:1477-87.

160. Weng F, Zhang S, Vuckovic I, Ryounghoon J, Lerman A, et al. Glycolytic stimulation is not a requirement for M2 macrophage differentiation. Cell Metab 2018;28:463-75.

161. Venter G, Oerlemans FTJJ, Wijers M, Willemse M, Fransen JAM, et al. Glucose controls morphodynamics of LPS-stimulated macrophages. PLoS One 2014;9:e96786.

162. Meiser J, Krämer L, Sapcariu SC, Battello N, Ghelfi J, et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J Biol Chem 2016;291:3932-46.

163. Shay JE, Celeste-Simon M. Hypoxia-inducible factors: crosstalk between inflammation and metabolism. Semin Cell Dev Biol 2012;23:389-94.

164. Liu PS, Wang H, Li X, Chao T, Teav T, et al. α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol 2017;8:985-94.

165. Moon JS, Hisata S, Park MA, DeNicola GM, Ryter SW, et al. mTORC1-induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation. Cell Rep 2015;12:102-15.

166. Xie M, Yu Y, Kang R, Zhu S, Yang L, et al. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. Nat Commun 2016;7:13280.

167. Wen H, Miao EA, Ting JP. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 2013;39:432-41.

168. Adamczak SE, de Rivero Vaccari JP, Dale G, Brand FJ, Nonner D, et al. Pyroptotic neuronal cell death mediated by the AIM2 inflammasome. J Cereb Blood Flow Metab 2014;34:621-29.

169. Kaushal V, Dye R, Pakavathkumar P. Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation. Cell Death Differ 2015;22:1676-86.

170. Yogarajah T, Ong KC, Perera D, Wong KT. AIM2 inflammasome-mediated pyroptosis in enterovirus A71-infected neuronal cells restricts viral replication. Sci Rep 2017;7:5845.

171. Minkiewicz J, de Rivero Vaccari JP, Keane RW. Human astrocytes express a novel NLRP2 inflammasome. Glia 2013;87:3655-67.

172. Freeman L, Guo H, David CN, Brickey WJ, Jha S, et al. NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes. J Exp Med 2017;214:1351-70.

173. de Rivero Vaccari JP, Dietrich WD, Keane RW. Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury. J Cereb Blood Flow Metab 2014;34:369-75.

174. Burm SM, Zuiderwijk-Sick EA, ‘t Jong AE, van der Putten C, Veth J, et al. Inflammasome-induced IL-1β secretion in microglia is characterized by delayed kinetics and is only partially dependent on inflammatory caspases. J Neurosci 2015;35:678-87.

175. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008;9:847-56.

176. Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009;10:241-7.

177. Hanamsagar R, Torres W, Kielian T. Inflammasome activation and IL-1beta/IL-18 processing are influenced by distinct pathways in microglia. J Neurochem 2011;119:736-48.

178. Lunov O, Syrovets T, Loos C, Nienhaus GU, Mailander V, et al. Amino-Functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages. ACS Nano 2011;5:9648-57.

179. Schnaars M, Beckert H, Halle A. Assessing β-amyloid-induced NLRP3 inflammasome activation in primary microglia. Methods Mol Biol 2013;1040:1-8.

180. Hughes MM, O’Neill LAJ. Metabolic regulation of NLRP3. Immunol Rev 2018;281:88-98.

181. Heid ME, Keyel PA, Kamga C, Shiva S, Watkins SC, et al. Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J Immunol 2013;191:5230-8.

182. Gustin A, Kirchmeyer M, Koncina E, Felten P, Losciuto S, et al. NLRP3 inflammasome is expressed and functional in mouse brain microglia but not in astrocytes. PLoS One 2015;19:10:e0130624.

183. Afonina IS, Zhong Z, Karin M, Beyaert R. Limiting inflammation - the negative regulation of NF-kB and the NLRP3 inflammasome. Nat Immunol 2017;18:861-9.

184. Elliott EI, Sutterwala FS. Initiation and perpetuation of NLRP3 inflammasome activation and assembly. Immunol Rev 2015;265:35-52.

185. Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol 2016;16:407-20.

186. Zambetti LP, Laudisi F, Licandro G, Ricciardi-Castagnoli P, Mortellaro A. The rhapsody of NLRPs: master players of inflammation...and a lot more. Immunol Res 2012;53:78-90.

187. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009;27:519-50.

188. Evavold CL, Ruan J, Tan Y, Xia S, Wu H, et al. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity 2018;48:35-44.e6.

189. Heilig R, Dick MS, Sborgi L, Meunier E, Hiller S, et al. The Gasdermin-D pore acts as a conduit for IL-1β secretion in mice. Eur J Immunol 2018;48:584-92.

190. Lee HM, Kang J, Lee SJ, Jo EK. Microglial activation of the NLRP3 inflammasome by the priming signals derived from macrophages infected with mycobacteria. Glia 2013;61:441-52.

191. Viganò E, Mortellaro A. Caspase-11: the driving factor for noncanonical inflammasomes. Eur J Immunol 2013;43:2240-5.

192. Franklin BS, Bossaller L, De Nardo D, Ratter JM, Stutz A, et al. The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation. Nat Immunol 2014;15:727-37.

193. Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, et al. Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease. Nature 2017;552:355-61.

194. Gurung P, Lukens JR, Kanneganti TD. Mitochondria: diversity in the regulation of NLRP3 inflammasome. Trends Mol Med 2015;3:193-201.

195. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012;36:401-14.

196. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011;12:222-30.

197. Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature 2018;560:198-203.

198. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011;469:221-5.

199. Bauernfeind F, Bartok E, Rieger A, Franchi L, Núñez G, et al. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol 2011;187:613-7.

200. Elliott EI, Miller A, Banoth B, Iyer SS, Stotland A, et al. Cutting edge: mitochondrial assembly of the NLRP3 inflammasome complex is initiated at priming. J Immunol 2018;200:3047-52.

201. Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, et al. Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies. PLoS One 2013;8:e55375.

202. Parajuli B, Sonobe Y, Horiuchi H, Takeuchi H, Mizuno T, et al. Oligomeric amyloid beta induces IL-1beta processing via production of ROS: implication in Alzheimer’s disease. Cell Death Dis 2013;4:e975.

203. Bellezza I, Grottelli S, Costanzi E, Scarpelli P, Pigna E, et al. Peroxynitrite activates the NLRP3 inflammasome cascade in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Mol Neurobiol 2018;55:2350-61.

204. Venegas C, Heneka MT. Inflammasome-mediated innate immunity in Alzheimer’s disease. FASEB J 2019;33:13075-84.

205. Deora V, Lee JD, Albornoz EA, McAlary L, Jagaraj CJ, et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia 2020;68:407-21.

206. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014;40:274-88.

207. Healy LM, Yaqubi M, Ludwin S, Antel JP. Species differences in immune-mediated CNS tissue injury and repair: a (neuro)inflammatory topic. Glia 2020;68:811-29.

208. Stoger JL, Gijbels MJ, van der Velden S, Manca M, van der Loos CM, et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 2012;225:461-8.

209. Van den Bossche J, O’Neill LA, Menon D. Macrophage immunometabolism: where are we (going)? Trends Immunol 2017;38:395-406.

Neuroimmunology and Neuroinflammation
ISSN 2349-6142 (Online) 2347-8659 (Print)


All published articles are preserved here permanently:


All published articles are preserved here permanently: